Singapore markets closed

Swedish Orphan Biovitrum AB (B6E.HA)

Hanover - Hanover Delayed Price. Currency in EUR
Add to watchlist
18.07-0.02 (-0.11%)
At close: 08:36AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
2,493,000
2,638,000
2,679,000
3,245,000
3,304,000
Depreciation & amortisation
2,365,000
2,419,000
2,006,000
2,023,000
1,589,000
Stock-based compensation
-
-
-
114,000
80,000
Change in working capital
-240,000
-806,000
1,114,000
-184,000
-1,666,000
Inventory
-
413,000
-318,000
-1,306,000
-459,000
Other working capital
3,229,000
3,188,000
5,100,000
1,362,000
-6,112,000
Other non-cash items
859,000
741,000
529,000
-351,000
-417,000
Net cash provided by operating activities
4,888,000
4,665,000
5,470,000
5,214,000
3,634,000
Cash flows from investing activities
Investments in property, plant and equipment
-1,659,000
-1,477,000
-370,000
-3,852,000
-9,746,000
Acquisitions, net
-
-
-
0
-12,880,000
Purchases of investments
-
-
0
-120,000
-
Sales/maturities of investments
-
-
-
-
0
Net cash used for investing activities
-1,659,000
-1,477,000
-367,000
-3,964,000
-21,685,000
Net change in cash
-33,000
197,000
629,000
-320,000
-2,271,000
Cash at beginning of period
212,000
1,045,000
404,000
737,000
2,999,000
Cash at end of period
179,000
1,361,000
1,045,000
404,000
737,000
Free cash flow
Operating cash flow
4,888,000
4,665,000
5,470,000
5,214,000
3,634,000
Capital expenditure
-1,659,000
-1,477,000
-370,000
-3,852,000
-9,746,000
Free cash flow
3,229,000
3,188,000
5,100,000
1,362,000
-6,112,000